Your Source for Venture Capital and Private Equity Financings

VC-funded Company:

Quench Bio
400 Technology Square, 10th Floor
Cambridge, MA 02139
https://quenchbio.com/

Quench Bio is a biotechnology company leveraging new insights into gasdermin biology and innate immunity to develop medicines for severe inflammatory diseases. Quench's lead compounds target and inhibit the pore-forming protein Gasdermin D, a central player in both pyroptosis and NETosis pathways that mediates the release of inflammatory cytokines, alarmins, DNA and NETs. Quench Bio launched in January 2020 with $50 million from leading life science investors including Atlas Venture, Arix Bioscience, RA Capital and AbbVie Ventures.

Key Contact
Name
Samantha Truex
Title
CEO
Funding Events

Date
Amount
Type
Investors
Valuation
01/27/20 $50,000,000 Series A AbbVie Biotech Ventures
Arix Bioscience
Atlas Venture
RA Capital Management
undisclosed


Featured Reading